|
 |
|
The most prominent faculty of the Angioplasty Summit-TCT Asia Pacific 2008 will share their experience and opinion in the interventional vascular field.
|
Bernhard
Chevalier, MD
Centre
Cardiologie du Nord, France
- Thromboaspiration in AMI, Saphenous Vein Graft Intervention
and NOBORI I Phase 2 |
|
Antonio
Colombo, MD
Columbus
Hospital and San Raffaele Hospital, Italy
- True Bifurcation Lesion Intervention, Side Branch Interventions
and CACTUS Trial |
|
Ted
Feldman, MD
Evanston
Hospital, USA
- Percutaneous Intervention in Valvular Heart Disease and Percutaneous
Mitral Valve Repair |
|
Eulogio
Garcia, MD
Hospital
Universitario Gregorio Marañón, Spain
- Szabo Stenting Technique and Differences in Coronary Intervention
Between Asia and Europe |
|
Eberhard
Grube, MD
Heart
Center Siegburg, Germany
- Next Generation DES, SPIRIT II -2 Year F/U, STEALTH II Pivotal Trial,
and XTENT System |
|
Ziyad
M. Hijazi, MD
Rush
University Medical Center, USA
- PFO Closure, ASD Closure and Coarctation of Aorta Stenting |
|
David
R. Holmes, MD
Mayo
Clinic, USA
- PCI is a Better Treatment Option Compared with CABG and COURAGE
Trial |
|
Adnan
Kastrati, MD
Deutsches
Herzzentrum München, Germany
- ISAR-REACT 3 and ISAR-Left Main |
|
Spencer
B. King III, MD
Fuqua
Heart Center, USA
- What Do You Expect 30 Years from Now in the Field of Coronary Intervention?
|
|
John
R. Laird, Jr., MD
UC
Davis Medical Center, USA
- The True-Lumen Reentry Device for Subintimal Angioplasty, SFA CTO
Intervention, Carotid Stenting and AAA Intervention |
|
Thierry
Lefèvre, MD
Institut
Hospitalier Jacques Cartier, France
- Nordic Stent Technique Study, bifurcation Lesion Intervention and
Euro CTO Club |
|
Martin
B. Leon, MD
NewYork-Presbyterian
Hospital / Columbia University Medical Center, USA
- The Hottest Issue in 2008 SCAI/ACCi2 Meeting, The Journey of PCI
from Empiricism to EBM, The Long-Term Outcomes of the Second Generation
DESs and Dedicated Bifurcation Stents |
|
Roxana
Mehran, MD
NewYork-Presbyterian
Hospital / Columbia University Medical Center, USA
- Clinical Trial Design, HORIZONS AMI Trial and Contrast Induced Nephropathy
|
|
Bernhard
Meier, MD
Swiss
Cardiovascular Center Bern, Switzerland
- Percutaneous PFO Closure |
|
Gary
S. Mintz, MD
Cardiovascular
Research Foundation, USA
- IVUS Guided PCI in the Era of DES and Gray Scale IVUS, VH- and IB-IVUS
|
|
Jeffrey
J. Popma, MD
St.
Elizabeth Medical Center, USA
- The Clinical Outcomes of DESs After 5 or 10 Years, Adjunctive Phamacology
After DES Implantation and Next Generation Stents |
|
Nicolaus
J. Reifart, MD
Main
Taunus Heart Institute, Germany
- CTO intervention and Peripheral Intervention Device |
|
Patrick
W. Serruys, MD
Erasmus
Medical Center, Thoraxcenter, The Netherlands
- SPIRIT II Trial, SYNTAX Trial and DELFT Registry |
|
Takahiko
Suzuki, MD
Toyohashi
Heart Center, Japan
- CTO Intervention: Retrograde Approach and MDCT Effect |
|
David
Paul Taggart, MD
University
of Oxford, United Kingdom
- PCI vs. CABG for Left Main Lesions |
|
Renu
Virmani, MD
CV
Path, Institute Inc., USA
- The Best Imaging Modality to Identify Vulnerable Plaque and Next
Generation DESs |
|
|
|
|
|
